Related Experiment Videos
Understanding atopic dermatitis: pathophysiology and etiology. Conclusion
1Clininque de Dermatologie, HUG, Geneva, Switzerland.
Journal of the American Academy of Dermatology
|June 26, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Microcomedones in non-lesional acne prone skin New orientations on comedogenesis and its prevention.
Journal of the European Academy of Dermatology and Venereology : JEADV·2019
RASopathic comedone-like or cystic lesions induced by vemurafenib: a model of skin lesions similar but not identical to those induced by dioxins MADISH.
Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Use of imatinib in a patient with cutaneous vasculopathy in the context of von Recklinghausen disease/neurofibromatosis.
The British journal of dermatology·2014
A toxicological and dermatological assessment of alkyl cyclic ketones when used as fragrance ingredients. RIFM Expert Panel.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2013
Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study.
Dermatology (Basel, Switzerland)·2012
Clinical outcomes associated with a digital standardized skin care regimen in acne-rosacea comorbidity: A real-world longitudinal study with cross-lagged and mediation analyses.
Journal of the American Academy of Dermatology·2026
Real-world outcomes of 24-week abrocitinib tapering in moderate-to-severe atopic dermatitis: Feasibility and regimen comparison.
Journal of the American Academy of Dermatology·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026